Overview
Lobbying Costs
150,000€
Financial year: Jan 2020 - Dec 2020
Lobbyists (Full time equivalent)
0.25 Fte (1)
Lobbyists with EP accreditation
0
High-level Commission meetings
4
Lobbying Costs over the years
-
Info
Moderna Inc.
EU Transparency Register
011080341579-06 First registered on 24 Feb 2021
Goals / Remit
Moderna’s mRNA technology quickly enabled us to pivot when the COVID-19 crisis emerged and to manufacture and deliver a safe, effective vaccine against COVID-19. In this context, Moderna made two agreements with the European Commission for Advance Purchase Agreements. The pioneering technology in our vaccine will be offered soon in other cures and therapies such as immuno-oncology, which will continue to deliver benefits to European citizens and see mRNA technology support new initiatives such as Europe’s Beating Cancer Plan.
Main EU files targeted
Moderna’s mRNA technology quickly enabled us to pivot when the COVID-19 crisis emerged and to manufacture and deliver a safe, effective vaccine against COVID-19. In this context, Moderna made two agreements with the European Commission for Advance Purchase Agreements. The pioneering technology in our vaccine will be offered soon in other cures and therapies such as immuno-oncology, which will continue to deliver benefits to European citizens and see mRNA technology support new initiatives such as Europe’s Beating Cancer Plan.
Address
Head Office
200 Technology Square
Cambridge 02139
UNITED STATES -
People
Total lobbyists declared
1
Employment time Lobbyists 25% 1 Lobbyists (Full time equivalent)
0.25
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
0 accreditations were / are live (in bold) for the selected state of 24 Feb 2021
Name Start date End Date Maren DR. VON FRITSCHEN 18 Jan 2024 17 Jan 2025 Mr Alexander DR. MEIER 18 Jan 2024 17 Jan 2025 Complementary Information
None declared
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
II - In-house lobbyists and trade/business/professional associations
Subcategory
Companies & groups
-
Networking
Affiliation
https://www.vaccineseurope.eu
Member organisations
None declared
-
Financial Data
Closed financial year
Jan 2020 - Dec 2020
Lobbying costs for closed financial year
150,000€
Other financial info
None declared
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
N/A
Communication activities
None
Other activities
None declared
- Meetings
Meetings
4 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
-
Date 03 Nov 2022 Location Bruxelles Subject Videoconference with Moderna CEO on future of mRNA platform; ongoing cooperation on the management of the pandemic Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Daphne von Buxhoeveden (Cabinet member)
- Stella Kyriakides (Commissioner)
-
Date 26 Nov 2021 Location Videoconference Subject Meeting with CEO of Moderna Cabinet Cabinet of President Ursula von der Leyen Portfolio President Attending - Ursula von der Leyen (President)
-
Date 10 Apr 2021 Location Videocall Subject Vaccine production and deliveries Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
Other Lobbyists -
Date 31 Jan 2021 Location Videoconference Subject Meeting with CEOs of the pharmaceutical companies with which the Commission has signed Advance Purchase Agreements Cabinet Cabinet of President Ursula von der Leyen Portfolio President Attending - Ursula von der Leyen (President)
Other Lobbyists
- Meetings